12.1 Local Anaesthesia
Key Takeaways
- Local anaesthetics block voltage-gated sodium channels in nerve fibres, preventing depolarisation and action potential propagation; small myelinated Aδ pain fibres are blocked before larger Aα motor fibres
- Lidocaine 2% with 1:80,000 epinephrine is the UK standard dental cartridge: 7 mg/kg with vasoconstrictor (500 mg adult absolute ceiling), delivering 44 mg lidocaine and approximately 27.5 micrograms epinephrine per 2.2 mL cartridge
- Articaine 4% with 1:100,000 epinephrine is lipid-soluble and achieves effective buccal infiltration anaesthesia for mandibular molars; maximum 7 mg/kg (500 mg ceiling, 88 mg per cartridge)
- True allergy to amide local anaesthetics (lidocaine, articaine, mepivacaine, bupivacaine) is rare; ester agents (benzocaine) carry a higher allergy risk via para-aminobenzoate (PABA) metabolites
- Bupivacaine 0.5% with 1:200,000 epinephrine is long-acting (6–8 hours) at 2 mg/kg maximum (200 mg ceiling), suited to prolonged postoperative analgesia rather than routine restorative work
Mechanism of Action
Local anaesthetics block voltage-gated sodium channels on nerve axons. By binding to the open sodium channel from the intracellular side, they prevent sodium influx, abolish depolarisation, and halt action potential propagation. Recovery is spontaneous as the drug diffuses away.
Nerve Fibre Sensitivity
Different nerve fibres are blocked in a predictable order. Small, myelinated fibres are most sensitive because the local anaesthetic has a shorter distance to reach the nodes of Ranvier.
| Fibre Type | Function | Myelin | Sensitivity to LA |
|---|---|---|---|
| Aδ | Sharp, fast pain | Myelinated | Blocked first |
| Aβ | Touch, pressure | Myelinated | Blocked early |
| Aγ | Muscle spindle tone | Myelinated | Blocked early |
| C | Dull, slow pain | Unmyelinated | Blocked later |
| Aα | Motor, proprioception | Myelinated | Blocked last |
This explains the clinical sequence: patients report loss of sharp pain before loss of touch or motor function.
Agents Used in UK Dental Practice
All routinely used dental injectable anaesthetics in the UK are amides. Ester agents survive mainly as topical preparations.
| Agent | Concentration | Vasoconstrictor | Max Dose (with vasoconstrictor) | Ceiling | Duration | Notes |
|---|---|---|---|---|---|---|
| Lidocaine | 2% | 1:80,000 epinephrine | 7 mg/kg | 500 mg | 60–90 min | UK standard; 44 mg per 2.2 mL cartridge |
| Articaine | 4% | 1:100,000 epinephrine | 7 mg/kg | 500 mg | 60–120 min | Lipid-soluble; effective buccal infiltration of mandibular molars; 88 mg per cartridge |
| Mepivacaine | 3% | Plain (no vasoconstrictor) | 6.6 mg/kg | 400 mg | 30–45 min | Short-acting; avoids epinephrine when contraindicated |
| Prilocaine | 4% | 1:200,000 epinephrine or felypressin | 8 mg/kg | 500 mg | 30–60 min | Methaemoglobinaemia risk at high dose; felypressin option for cardiac patients |
| Bupivacaine | 0.5% | 1:200,000 epinephrine | 2 mg/kg | 200 mg | 6–8 h | Long-acting; for prolonged postoperative analgesia; slow onset |
Dose Calculation in Practice
A 70 kg adult receiving lidocaine 2% with 1:80,000 epinephrine:
- Weight-based limit: 7 mg/kg × 70 kg = 490 mg (below the 500 mg absolute ceiling)
- Cartridges to reach weight limit: 490 ÷ 44 mg ≈ 11 cartridges (lidocaine limit)
- Epinephrine is the practical limiting factor: a healthy-adult epinephrine ceiling of approximately 200 micrograms per appointment ÷ 27.5 µg per cartridge ≈ 7–8 cartridges. For patients with cardiac disease, the cautious epinephrine ceiling is approximately 40 micrograms (~1–2 cartridges).
Always use the most conservative of the weight-based and epinephrine-based limits.
Vasoconstrictors
Epinephrine (adrenaline) is added to local anaesthetics to cause local vasoconstriction, which:
- Reduces systemic absorption, lowering toxicity risk and extending duration
- Decreases bleeding at the operative site
- Increases the effective maximum safe dose
Concentrations are expressed as ratios: 1:80,000 (lidocaine) and 1:100,000 (articaine). Felypressin (octapressin), a synthetic vasopressin analogue, is paired with prilocaine as an alternative for patients in whom epinephrine must be minimised, although it has weaker vasoconstrictor action.
Epinephrine Cautions
Epinephrine is not absolutely contraindicated in most cardiac disease, but caution is required. Safe practice:
- Aspirate before injecting to avoid intravascular delivery
- Use the lowest effective concentration and volume
- Avoid in uncontrolled hyperthyroidism and unstable cardiac disease
- Limit to approximately 40 micrograms epinephrine (about 1–2 cartridges of 1:80,000) for patients with significant cardiovascular disease
- True absolute contraindications to epinephrine are rare; the risk of epinephrine is generally lower than the risk of giving plain anaesthetic that fails to achieve adequate analgesia
Allergy to Local Anaesthetics
True allergy is uncommon but clinically important.
- Amide agents (lidocaine, articaine, mepivacaine, bupivacaine, prilocaine): allergy is rare. Reactions reported are more often vasovagal, toxicity, or epinephrine side effects.
- Ester agents (benzocaine, procaine, amethocaine): higher allergy risk because they are metabolised to para-aminobenzoate (PABA), a known allergen. Cross-reactivity exists across ester agents but not with amides.
If a patient reports a genuine amide allergy, refer to allergy testing — do not assume all amides are contraindicated without confirmation.
Topical Anaesthesia
Topical agents anaesthetise mucosa before injection or for minor procedures:
- Lidocaine 5% ointment or 4% gel — widely used; amide, low allergy risk
- Benzocaine 20% gel — ester; risk of methaemoglobinaemia, especially in children, infants, and patients with G6PD deficiency
Topical should be applied to dried mucosa for 1–2 minutes and used sparingly.
Injection Techniques
| Technique | Target | Typical Use |
|---|---|---|
| Local infiltration | Apex of maxillary teeth, mandibular incisors | Restorative work where bone is thin |
| Inferior alveolar (ID) block | Mandibular nerve at lingula | Mandibular molars and premolars; thick cortical bone |
| Mental / incisive block | Mental foramen | Mandibular premolars and incisors |
| Posterior superior alveolar (PSA) block | Maxillary molars | Upper molars where infiltration is inadequate |
| Anterior superior alveolar (ASA) block | Maxillary anteriors | Upper anterior teeth |
| Intraligamentary (PDL) injection | Periodontal ligament | Single tooth, low systemic dose; delivers ~0.2 mL per root |
Articaine's lipid solubility has expanded the role of buccal infiltration in the mandible, reducing reliance on the ID block for some restorative procedures, though the ID block remains standard for profound pulpal anaesthesia of mandibular molars.
A fit 70 kg adult is receiving lidocaine 2% with 1:80,000 epinephrine for restorative dentistry. Each 2.2 mL cartridge contains 44 mg lidocaine and approximately 27.5 micrograms epinephrine. What is the most important practical factor limiting the number of cartridges you can safely administer at one appointment?
A patient reports a documented allergy to benzocaine. Which local anaesthetic agent is the safest choice for routine dental treatment, and why?
Which local anaesthetic formulation is most appropriate for providing prolonged postoperative analgesia after surgical extraction of a mandibular third molar, and what is its maximum dose?
Why are small myelinated Aδ nerve fibres blocked by local anaesthetic before larger Aα motor fibres?